Loading…
A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Legislative Progress
Momentum (last 30 days)
0
score
0 actions · 0 new cosponsors · 0 votes
Speed vs cohort
0pct
0d open
vs 4,048 other S bills in the 111th — cohort avg 29d
No CRS summary is available for this bill yet. The source title, actions, sponsors, and text versions below come from Congress.gov.
These links require the bill number to appear in the filing's source-reported specific issue text. Client expenses and lobbying-firm income are separate disclosure fields.
Bills with similar content found using semantic analysis.
Sources: Congress.gov
2010 · fourth_quarter · Health Issues
Various issues surrounding health care reform. HR 3200, HR 1339, S 1235, HR 1392, S 1221, HR 3590, HR 1188, S 468, HR 1765, HR 4827, S.701, HR 4985, H.RES 1444, HR 5597, HR 2400, HR 1549, HR 5106.
Client expense: Not reported · Firm income: $80,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Medicare/Medicaid
Medicare payments to community oncology practices covered by Medicare Part B reimbursement. H.R. 1392 & S. 1221 - To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare program. H.R. 3675 - National Quality Cancer Care Demonstration Project Act of 2009 General Health Care Reform Legislation - All bill versions 2010 Medicare Physician Fee Schedule
Client expense: Not reported · Firm income: $20,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
S. 1221, To amend title XVIII of the Social Security Act H.R. 1392, To amend title XVIII of the Social Security Act
Client expense: $280,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Medicare/Medicaid
H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Pharmacy
H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
| Democratic |
| NC |
| Lamar Alexander | Republican | TN |
| Pat Roberts | Republican | KS |
| Richard Burr | Republican | NC |
| Robert Bennett | Republican | UT |
| Robert P. Casey, Jr. | Democratic | PA |
| Sherrod Brown | Democratic | OH |
2010 · fourth_quarter · Medicare/Medicaid
H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: $396,145 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Pharmacy
H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: $396,145 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
- CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions. - H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions. - S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions. - H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP. - Implementation of Health Care Reform Bill: Medicare Wellness Benefit. - H.R. 6130, "Strengthening Medicare Anti-Fraud Measures Act of 2010", regarding all provisions.
Client expense: $850,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
2010 · fourth_quarter · Medicare/Medicaid
H.R. 1392 and S.1221- American Prompt Pay Correction Act; Issues related to Medicare drug reimbursement; H.R. 4872 - Health Care and Education Reconciliation Act of 2010.
Client expense: Not reported · Firm income: $40,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
HR 1765: Medicare IVIG Home Infusion Legislation HR 1392: Medicare Part B Prompt-Pay Legislation S 701: "Medicare Patient IVIG Access Act of 2009" HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration project S 1221: A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B HR 2939 - Legislation to create a Medicare Oncology Pilot Program HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price Methodology HR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V. chemotherapy. HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients. America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price Methodology. 2010 Medicare Physician Fee Schedule Affordable Healthcare for American Act Patient Protection and Affordable Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Health Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B HR 2939 - Legislation to create a Medicare Oncology Pilot Program HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price Methodology HR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V. chemotherapy. HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients. America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price Methodology. 2010 Medicare Physician Fee Schedule Affordable Healthcare for American Act Patient Protection and Affordable Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
S. 1221, To amend title XVIII of the Social Security Act H.R. 1392, To amend title XVIII of the Social Security Act
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Medicare/Medicaid
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1844) all provisions; Cancer Trial Coverage (S. 717) -- all provisions; Legislation eliminating the prompt-pay discount from the Medicare average sales price calculation (H.R. 1392; S. 1221); Medicare Cancer Patients Database and Coverage Act (H.R. 3095) -- all provisions; Eliminating Disparities in Breast Cancer Treatment Act (H.R. 2279) - all provisions] Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments; Reform of Medicare physician fee schedule and formula [Medicare and Medicaid Extenders Act (H.R. 4994)]
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · fourth_quarter · Medicare/Medicaid
Pharmaceutical Distribution Reimbursement H.R.1392/S.1221 -- Excluding customary prompt pay discounts from ASP Implementation of Patient Protection and Affordable Care Act of 2010
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · fourth_quarter · Medicare/Medicaid
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors H.R. 4994, Medicare and Medicaid Extenders Act of 2010
Client expense: $21,825 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
Various issues surrounding health care reform. HR 3200, HR 1339, S 1235, HR 1392, S 1221, HR 3590, HR 1188, S 468, HR 1765, HR 4827, S.701, HR 4985, H.RES 1444, HR 5597, HR 2400, HR 1549, HR 5106.
Client expense: Not reported · Firm income: $110,000
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Medicare/Medicaid
Medicare payments to community oncology practices covered by Medicare Part B reimbursement. H.R. 1392 & S. 1221 - To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare program. H.R. 3675 - National Quality Cancer Care Demonstration Project Act of 2009 General Health Care Reform Legislation - All bill versions 2010 Medicare Physician Fee Schedule
Client expense: Not reported · Firm income: $15,000
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
H.R. 1392 and S.1221- American Prompt Pay Correction Act; Issues related to Medicare drug reimbursement; H.R. 4872 - Health Care and Education Reconciliation Act of 2010.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
H.R. 1392, to amend Title XVIII of the Social Security Act S. 1221, to amend Title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, a bill to amend the Federal Food, Drug and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountability Act of 2009 S. 301, to amend the Title XI of the Social Security Act Health information technology issues
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Medicare/Medicaid
S. 1221, To amend title XVIII of the Social Security Act H.R. 1392, To amend title XVIII of the Social Security Act
Client expense: $110,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Pharmacy
H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B HR 2939 - Legislation to create a Medicare Oncology Pilot Program HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price Methodology HR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V. chemotherapy HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients. America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price Methodology 2010 Medicare Physician Fee Schedule Affordable Healthcare for American Act Patient Protection and Affordable Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Health Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B HR 2939 - Legislation to create a Medicare Oncology Pilot Program HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price Methodology HR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V. chemotherapy HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients. America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price Methodology 2010 Medicare Physician Fee Schedule Affordable Healthcare for American Act Patient Protection and Affordable Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Pharmacy
H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
- CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions. - H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions. - S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions. - H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP. - Implementation of Health Care Reform Bill: Medicare Wellness Benefit. - H.R. 6130, "Strengthening Medicare Anti-Fraud Measures Act of 2010", regarding all provisions.
Client expense: $2,410,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
2010 · third_quarter · Health Issues
H.R. 1392, to amend Title XVIII of the Social Security Act S. 1221, to amend Title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, a bill to amend the Federal Food, Drug and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountability Act of 2009 S. 301, to amend the Title XI of the Social Security Act Health information technology issues
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Medicare/Medicaid
S. 1221, To amend title XVIII of the Social Security Act H.R. 1392, To amend title XVIII of the Social Security Act
Client expense: Not reported · Firm income: $30,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Medicare/Medicaid
Medicare physician reimbursement, medical imaging, prompt pay discount (HR 1392/S. 1221), Medicare wellness visit
Client expense: $139,635 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Medicare/Medicaid
Pharmaceutical Distribution Reimbursement H.R.1392/S.1221 -- Excluding customary prompt pay discounts from ASP Implementation of Patient Protection and Affordable Care Act of 2010
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1844) all provisions; Cancer Trial Coverage (S. 717) -- all provisions; Legislation eliminating the prompt-pay discount from the Medicare average sales price calculation (H.R. 1392; S. 1221); Medicare Cancer Patients Database and Coverage Act (H.R. 3095) -- all provisions; Eliminating Disparities in Breast Cancer Treatment Act (H.R. 2279) - all provisions] Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · third_quarter · Medicare/Medicaid
HR 1765: Medicare IVIG Home Infusion Legislation HR 1392: Medicare Part B Prompt-Pay Legislation S 701: "Medicare Patient IVIG Access Act of 2009" HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration project S 1221: A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: $10,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
HR 1765: Medicare IVIG Home Infusion Legislation HR 1392: Medicare Part B Prompt-Pay Legislation S 701: "Medicare Patient IVIG Access Act of 2009" HR 2002: Medicare Patient IVIG Access Act HR 5597: Medicare Patient IVIG Access Demonstration project S 1221: A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · third_quarter · Medicare/Medicaid
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors SGR Repeal, advocacy for the repeal and temporary SGR extension (H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010)
Client expense: $30,656 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
H.R. 1392 and S. 1221- an act to ensure more appropriate payment for drugs under Medicaer Part B; seeking cosponsors Medicare Reimbursement for Chemotherapy Drugs H.R. 3095, Medicare Cancer Patient Database and Coverage Act, seeking cosponsors SGR Repeal, advocacy for the repeal and temporary SGR extensions (H.R. 4213, a bill to extend certain tax policies and stimulate job growth; H.R. 4581, the Continuing Extensions Act of 2010; and H.R. 3962, Preservation of Access to Care for Medicare Beneficiaries and Pension Relief Act of 2010.)
Client expense: $53,175 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), HOUSE OF REPRESENTATIVES, Office of Management & Budget (OMB), SENATE
2010 · second_quarter · Health Issues
Various issues surrounding health care reform. HR 3200, HR 1339, S 1235, HR 1392, S 1221, HR 3590, HR 1188, S 468, HR 1765, HR 4827, S.701, HR 4985, H.RES 1444, HR 5597, HR 2400, HR 1549, HR 5106.
Client expense: Not reported · Firm income: $70,000
Government targets: Executive Office of the President (EOP), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 S. 1221, To amend Title XVIII of the Social Security Act
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Health Issues
H.R. 3590, Patient Protection and Affordable Care Act H.R. 4872, Health Care and Education Reconciliation Act of 2010 H.R. 1392, To amend Title XVIII of the Social Security Act S. 1221, To amend Title XVIII of the Social Security Act H.R. 759, Food and Drug Administration Globalization Act of 2009 S. 525, A bill to amend the Federal Food, Drug and Cosmetic Act S. 1232, Pharmaceutical Market Access and Drug Safety Act of 2009 S. 80, Pharmaceutical Market Access Act of 2009 S. 882, Drug and Device Accountability Act of 2009 S. 301, To amend Title XI of the Social Security Act Health information technology issues
Client expense: $240,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE
2010 · second_quarter · Medicare/Medicaid
H.R. 1392 and S.1221- American Prompt Pay Correction Act; Issues related to Medicare drug reimbursement; H.R. 3200 - America's Affordable Health Choices Act of 2009; S. 1679 - Affordable Health Choices Act of 2009 and H.R. 4872 - Health Care and Education Reconciliation Act of 2010.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Pharmacy
H.R. 1392 and S. 1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: $290,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
- H.R. 1392, "To amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sales price", regarding all provisions. - CMS 4138-IFC4, "Medicare Advantage and Prescription Drug Programs MIPPA Drug Formulary and Protected Classes Policies", regarding all provisions. - H.R. 684 / S. 330, "To amend title XVIII of the Social Security Act to deliver a meaningful benefit and lower prescription drug prices under the Medicare Program", regarding all provisions. - S. 883, "A bill to amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1616, "To amend title XIX of the Social Security Act to permit States the option to provide Medicaid coverage for low-income individuals infected with HIV", regarding all provisions. - H. R. 1392 / S. 1221, "A bill to amend title XVIII of the Social Security Act to ensure more appropriate payment amounts for drugs and biologicals under part B of the Medicare Program by excluding customary prompt pay discounts extended to wholesalers from the manufacturer's average sale price", regarding all provisions. - H.R. 3138/ S. 301, "A bill to amend title XI of the Social Security Act to provide for transparancy in the relationship between physicians and manufacturers of drugs, devices, biologicals, or medical supplies for which payment is made under Medicare, Medicaid, or SCHIP.
Client expense: $1,150,000 · Firm income: Not reported
Government targets: HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE, Treasury, Dept of
2010 · second_quarter · Pharmacy
H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
H.R.1392 and S.1221, legislation to ensure more appropriate general payment amount for drugs and biologicals under Part B of the Medicare Program by excluding customary prompt-pay discounts extended to wholesalers from the manufacturer's average sales price.
Client expense: Not reported · Firm income: $30,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B HR 2939 - Legislation to create a Medicare Oncology Pilot Program HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program Average Sale Price Methodology HR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V. chemotherapy HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients. America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price Methodology 2010 Medicare Physician Fee Schedule Affordable Healthcare for America Act Patient Protection and Affordable Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Health Issues
HR 1392/S 1221 - Legislation to ensure payment amounts for drugs and biologicals under Medicare Part B HR 2939 - Legislation to create Medicare Oncology Pilot Program HR 3200 - House Healthcare Reform Bill - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price Methodology HR 2366 - Legislation that requires insurance plans to provide equal coverage of oral chemotherapy drugs relative to I.V. chemotherapy HR 1927 - Legislation to encourage physicians to provide treatment plans to cancer patients. America's Healthy Future Act - Accountable Care Organizations, Medicare Shared Savings Program, Average Sale Price Methodology 2010 Medicare Physician Fee Schedule Affordable Healthcare for America Act Patient Protection and Affordable Act
Client expense: $120,000 · Firm income: Not reported
Government targets: Centers For Medicare and Medicaid Services (CMS), Government Accountability Office (GAO), HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
Health care reform Pharmaceutical distribution reimbursement HR1392/S1221-- Excluding customary prompt pay discounts from ASP
Client expense: Not reported · Firm income: $15,000
Government targets: HOUSE OF REPRESENTATIVES, SENATE
2010 · second_quarter · Medicare/Medicaid
Issues pertaining to the federal government's regulation and coverage of cancer care and treatments [Comprehensive Cancer Care Improvement Act (H.R. 1844) all provisions; Cancer Trial Coverage (S. 717) -- all provisions; Legislation eliminating the prompt-pay discount from the Medicare average sales price calculation (H.R. 1392; S. 1221); Medicare Cancer Patients Database and Coverage Act (H.R. 3095) -- all provisions; Eliminating Disparities in Breast Cancer Treatment Act (H.R. 2279) - all provisions] Health reform implementation issues pertaining to the regulation and coverage of cancer care and treatments
Client expense: Not reported · Firm income: $60,000
Government targets: Centers For Medicare and Medicaid Services (CMS), Food & Drug Administration (FDA), HOUSE OF REPRESENTATIVES, Health & Human Services, Dept of (HHS), SENATE